Results 91 to 100 of about 5,054 (133)

An Appraisal of the Preventive Effect of Statins on the Development of Graves’ Ophthalmopathy: A Hospital-Based Cohort Study

Ophthalmology and Therapy
Introduction Graves’ ophthalmopathy (GO) is an autoimmune inflammatory disorder observed in a substantial proportion of patients with Graves’ disease (GD), with debilitating symptoms of disfiguring, periorbital pain, dry eyes, diplopia, and even visual ...
Grace Chia-Yen Hsu, Shyang-Rong Shih, Fang-Yu Chang, Shu-Lang Liao, Yi-Hsuan Wei   +4 more
doaj   +1 more source

Prevalence of Graves ophthalmopathy among patients with thyroid disease

Philippine Journal of Ophthalmology, 2010
Objective: This study determined the prevalence of Graves ophthalmopathy among thyroid-disease patients at a tertiary government hospital. Methods: Patients with thyroid disease seen at a tertiary hospital from February to September 2007 were enrolled.
Erwin D. Palisoc, MD, Evelyn S. Morabe, MD, Paulo Ma. N. Pagkatipunan, MD   +2 more
doaj  

Long-term follow-up of seven patients with ophthalmopathy not associated with thyroid autoimmunity: heterogeneity of autoimmune ophthalmopathy

Clinical Ophthalmology, 2012
Tom McCorquodale,1 Hooshang Lahooti,1 Bamini Gopinath,2 Jack R Wall11Department of Medicine, Nepean Clinical School, the University of Sydney, Penrith, NSW, Australia; 2Centre for Vision Research, the University of Sydney, Westmead Hospital, Westmead ...
McCorquodale T, Lahooti H, Gopinath B, Wall JR   +3 more
doaj  

TEMPORAL RELATIONSHIP BETWEEN THE ONSET OF THYROID DERMOPATHY AND GRAVES' OPHTHALMOPATHY [PDF]

Acta Medica Iranica, 1993
Pretibial myxedema is an uncommon manifestation of Graves' disease and because of its rarity, information regarding its natural course and its relationship with other manifestations of Graves' disease is not sufficient."nWe reviewed 150 ...
Mohammad Pajhouhi
doaj  

Steroid Treatment Focused Management of Graves’ Ophthalmopathy

Acta Medica Bulgarica
Graves' disease (GD) is an autoimmune disease that affects the thyroid and the eyes. Graves' ophthalmopathy (GO), an autoimmune disease, usually appears 18 months after GD diagnosis.
Condeng Y. H., Umar H., Aman A. M., Rasyid H., Bakri S., Iskandar H.   +5 more
doaj   +1 more source

UEG Week 2025 Poster Presentations

United European Gastroenterology Journal, Volume 13, Issue S8, Page S803-S1476, October 2025.
wiley   +1 more source

Hyperthyroid heart disease: Diagnostic and therapeutic aspects [PDF]

, 1990
Reinwein, Dankwart, Scriba, P. C., Scriba, Peter Christian   +2 more
core   +1 more source

Graves' ophthalmopathy

Swiss Medical Weekly, 2002
Swiss Medical Weekly
doaj   +1 more source

Update on the medical treatment of Graves’ ophthalmopathy

International Journal of General Medicine, 2009
Gregory J Griepentrog, James A GarrityDepartment of Ophthalmology, Mayo Clinic, Rochester, MN, USAPurpose: To review recent advances in the understanding of Graves’ ophthalmopathy (GO) pathogenesis as well as discuss current and future medical ...
Gregory J Griepentrog, James A Garrity
doaj  

Psychological aspects of Graves’ ophthalmopathy

Endocrine Connections
Purpose: This review aims to discuss the psychological aspects of Graves’ ophthalmopathy (GO), estimate the prevalence of depression and anxiety disorders in GO, examine whether these psychiatric disorders are more prevalent in GO than in Graves’ disease
Waleed K W Al-Badri, Hinke Marijke Jellema, Arnaud R G G Potvin, Ruth M A van Nispen, Peter H Bisschop, Peerooz Saeed   +5 more
doaj   +1 more source